View in EDS

Cardiotoxicity of trametinib monotherapy in adults with neurofibromatosis type 1: Results from the TRAIN study.

Saved in:

Bibliographic Details
Title:	Cardiotoxicity of trametinib monotherapy in adults with neurofibromatosis type 1: Results from the TRAIN study.
Authors:	Ditta SA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Noordhoek DC; Department of Neurology / Neuro-oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Jongbloed F; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Meijers WC; Department of Cardiology, Erasmus University Medical Centre, Rotterdam, the Netherlands., Van den Bent MJ; Department of Neurology / Neuro-oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Bos MEMM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Taal W; Department of Neurology / Neuro-oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Manintveld OC; Department of Cardiology, Erasmus University Medical Centre, Rotterdam, the Netherlands. Electronic address: o.manintveld@erasmusmc.nl.
Source:	Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2026 May; Vol. 198, pp. 119251. Date of Electronic Publication: 2026 Mar 20.
Publication Type:	Journal Article; Clinical Trial, Phase II
Journal Info:	Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1950-6007
DOI:	10.1016/j.biopha.2026.119251